This study is currently not recruiting participants.

The Effect of Protocolized Management of COPD on Exacerbation Rates and Hospital Admission Rates

Investigating a Protocol for COPD Management

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to evaluate the use of a protocol that we have developed for COPD management. The protocol is based on the best available evidence in the medical field. We want to assess whether using this protocol leads to decreased COPD wor

Detailed description of study

The purpose of this study is to evaluate the use of a protocol that we have developed for COPD management. The protocol is based on the best available evidence in the medical field. We want to assess whether using this protocol leads to decreased COPD wor

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: COPD
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate a protocol for managing Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung conditions that cause breathing difficulties. The study aims to evaluate whether using this protocol can reduce the worsening of COPD symptoms.

Participants will follow a specific protocol designed for COPD management. This protocol is developed based on the best available evidence in the medical field. The study will involve monitoring the participants' health to see if the protocol effectively manages their COPD symptoms.

  • Who can participate: Eligible participants include individuals aged 40 to 80 years who have been diagnosed with moderate to severe COPD. Key eligibility factors include a history of smoking and no recent exacerbations.
  • Study details: Participants will follow a protocol for COPD management. This involves specific actions and monitoring to see if it helps manage symptoms.
Updated on 19 Feb 2024. Study ID: 1208009302

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team